Training & Education

Mammography topics

Future of Breast Cancer Screening with Digital Breast Tomosynthesis

Full-field digital mammography (FFDM) is currently the gold standard in breast cancer screening.1 It delivers high-resolution images of the breast, but it has a limitation that’s inherent to the acquisition method: tissue superimposition. Among this challenge in breast screening are interval cancers and until now 20-25% of interval cancers are classified as being missed as false negatives2.
To resolve this issue, in recent years digital breast tomosynthesis (DBT) has been introduced in clinical practice and in the near future it may replace digital mammography as the breast screening modality of choice.

Which breast imaging technologies challenge digital mammography in breast screening: The latest results of clinical trials were presented at a Breast Care Day symposium at the ECR 2022. The studies were analyzed in terms of their effectiveness in population screening. A special focus was put on the detection of interval cancers breast as a good performance indicator for the efficiency of a screening method3